RNA-guided gene activation by CRISPR-Cas9–based transcription factorsPablo Pérez‐Piñera, Charles A. Gersbach, D. Dewran Koçak et al.|Nature Methods|2013Cited by 1.3k
Multiplex CRISPR/Cas9-based genome editing for correction of dystrophin mutations that cause Duchenne muscular dystrophyDavid G. Ousterout, Charles A. Gersbach, Ami M. Kabadi et al.|Nature Communications|2015Cited by 456
Targeted long-read sequencing identifies missing disease-causing variationDanny E. Miller, Evan E. Eichler, Winston Lee et al.|The American Journal of Human Genetics|2021Cited by 239
Correction of Dystrophin Expression in Cells From Duchenne Muscular Dystrophy Patients Through Genomic Excision of Exon 51 by Zinc Finger NucleasesDavid G. Ousterout, Charles A. Gersbach, Ami M. Kabadi et al.|Molecular Therapy|2014Cited by 111
Neuronal and glial 3D chromatin architecture informs the cellular etiology of brain disordersBenxia Hu, Alexander W. Charney, Hyejung Won et al.|Nature Communications|2021Cited by 107